Sarcoma News

SAN ANTONIO — Creating a dynamic regulatory environment requires the FDA is responsive to societal demands in conjunction with emerging scientific advances, according to Richard Pazdur, MD.

The CDC has released a public-use research database that combines data from CDC’s National Program of Cancer Registries and NCI’s SEER program.

Children diagnosed with cancer and insured by Medicaid had similar survival rates as privately insured children, according to the results of a study published in Cancer.

Limited-margin radiotherapy using conformal external-beam radiotherapy or brachytherapy provided a high rate of local tumor control without increased marginal failures among children and young adults with nonrhabdomyosarcoma soft tissue sarcoma, according to the results of a phase 2 study published in Cancer.

A quarter of older adults newly diagnosed with cancer from 2009 to 2013 had a prior cancer history, according to an observational study published in JAMA Oncology.

NEW YORK — Every patient with cancer does not live in a major metropolitan area with direct access to specialized care, but there are ways to provide individuals access to necessary state-of-the-art care and clinical trials regardless of where they live, according to a speaker at Chemotherapy Foundation Symposium.

One-fifth of patients with cancer experienced PTSD within several months of diagnosis, according to results of a prospective study published in Cancer.

Nita Ahuja, MD, has been named chair of the department of surgery at Yale School of Medicine.

WASHINGTON — When diagnosed with Hodgkin lymphoma at the age of 33 years, FDA Commissioner Scott Gottlieb, MD, was told he had a 90% chance of survival.

The FDA today authorized Integrated Mutation Profiling of Actionable Cancer Targets, or IMPACT, an in vitro diagnostic test that uses next-generation sequencing to rapidly identify the presence of mutations in 468 genes.